Scientists have found that the presence of the SARS-CoV-2 spike protein in the plasma could be a hallmark of long COVID. The results show that the virus can linger in the body of patients who suffer from prolonged symptoms.
https://www.pharmalive.com/wp-content/uploads/2022/07/LongCOVID-Biospace-2022.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-07-11 09:00:092022-07-11 10:20:17Long COVID evidence begins to mount, suggesting biomarkers and a “triangle” effect
